Current Medical Research and Opinion · 2020 · 34 citations · 19 references
MedicineCardiologyPharmacotherapyCardiovascular PharmacotherapyClinical PharmacologyPharmacovigilanceAnticoagulant TherapyAntithrombotic TherapyAtrial FibrillationStrokeThromboembolism PreventionThrombosisAnticoagulant Prescribing SafetyAnticoagulation RegimenClinical Effectiveness CriteriaClinical Effectiveness MeasurementComparative Clinical EffectivenessLow Body Mass IndexStroke EmbolismVenous Thromboembolism Assessment
Among obese NVAF patients, prescription of rivaroxaban was associated with a reduced risk of SSE and major bleeding compared to warfarin, which remained consistent across BMI classes.
19